key: cord-0983096-na0f1l8j
authors: Mattace-Raso, Francesco; Pilotto, Alberto
title: The challenge of the multifaceted prognosis in the older people and the Multidimensional Prognostic Index
date: 2021-02-23
journal: Eur Geriatr Med
DOI: 10.1007/s41999-021-00457-9
sha: 7480f92e3561a40ec11478628a8413f8d0427d7f
doc_id: 983096
cord_uid: na0f1l8j

nan

An accurate assessment of prognosis may have a crucial role in clinical decision making of the older people [1] . An increasing body of evidences indicates that the prognosis of older patients is strongly related to the presence of concomitant diseases and to the degree of physical, cognitive, biological, and social impairment [2] .

The Comprehensive Geriatric Assessment (CGA) is the tool of choice to effectively explore these domains of health, especially in the functionally compromised and frail older subject [3] . The Multidimensional Prognostic Index (MPI) is a product of the CGA, that uses a mathematic algorithm including information about eight domains relevant for the global assessment of the older subjects (i.e., functional and cognitive status, nutrition, mobility and risk of pressure sores, multimorbidity, polypharmacy and co-habitation), to generate a numeric score (or index), between 0 and 1, that expresses the global risk of multidimensional impairment [4] . In this sense, we can say that MPI is able to translate the clinical evaluation of the CGA in a score that can accurately predict overall mortality and other negative outcomes, and therefore, be used as prognostic tool in older people.

The MPI was initially developed and validated as a prognostic index predicting mortality in hospitalized older patients [5] . A modified MPI, including the mini nutritional assessment short-form (MNA-SF), showed similar degree of accuracy as the original MPI, but could be completed in around 20 min [6] . Other versions of the MPI have been developed and validated in large populations of community-dwelling older subjects who underwent a standard CGA to be admitted to public health facilities, i.e., homecare services or nursing homes [7] as well as in population-based cohorts of older subjects living at home or in an institution in Sweden [8], Italy [9], Ireland [10] and in the United States within the framework of the osteoarthritis initiative (OAI) [11] . All these studies confirmed the accuracy of the MPI in predicting life expectancy [8, 9] and the risk of hospitalization [8] during long periods of follow-up (from 12 to over 15 years) as well as the long-term risk of incident depression [10] and falls [11] . Moreover, in the context of the EU co-funded project EFFICHRONIC a self-administered version of the MPI (SELFY_MPI) was developed and validated as screening tool for communitydwelling patients with chronic diseases (or their caregivers) candidate to be managed through a self-management program [12, 13]; a short-form version of the SELFY_MPI was developed for older patients who attended an ambulatory visit by their general practitioners [14] . Very recently, a telephone-administered version of the MPI (TELE-MPI) was also developed and validated for remote monitoring of older adults during COVID-19 pandemic [15] .

In the current issue of Eur Geriatr Med, Hansen et al. evaluated the predictive value of a previously validated [16] record-based MPI including data of the inpatient's electronic medical records to assess multidimensional frailty in a large cohort of 1.190 medical inpatients aged ≥ 75 years [17] . The results demonstrated that the record-based MPI, assessed at discharge in hospitalized older patients, accurately predicted post-discharge mortality (after 90-days and 1 year) and hospital readmissions in a dose-dependently manner; moreover the MPI value was associated with the hospital length-of-stay. These findings further support the concept that the MPI, although derived from different assessment scales in different settings (provided that these scales accurately explore all the domains linked to the multidimensional impairment), is able to express numerically the global health and functions to implement a multidimensional approach to the assessment of frailty in older people [18] . Indeed, the MPI is currently one of the most commonly used tools for evaluating frailty, both in primary care and hospital settings [19] .

Large multicenter studies including more than 60.000 older subjects in different settings showed that the CGAbased MPI is able to: (1) predict mortality more accurately than other frailty instruments based on both phenotypic and multiple-deficits models [ [46] . Finally, very recently independent studies demonstrated that the MPI could also extend to specific areas for personalized therapies such as for guiding immunotherapy in patients with advanced malignancies [47] or helping physicians in clinical decisions for older adults with chronic kidney disease on conservative treatment or renal replacement (hemodialysis or peritoneal dialysis) [48] , or with acute myocardial infarction who underwent a percutaneous coronary intervention (PCI) [49] , and in older patients candidate to elective surgery for colon-rectal cancer [50] or to non-invasive ventilation for acute respiratory failure [51] . Promising findings from all these studies showed that in older adults the multidimensional approach warrants better clinical decisions (i.e., to treat or not to treat) depending on degree of multidimensional impairment of the subject. For these reasons the implementation of new MPI versions that facilitate the calculation of the MPI directly from information included in the clinical records such as the record-based MPI [16], as reported in the article of Hansen et al. [17] , should be recommended to physicians to enhance the diffusion in clinical practice of the multidimensional approach to the frail older patient [18] . This seems to be particularly important during the recent COVID-19 pandemic in which an accurate prognosis, as improved by including physical and cognitive functioning information to age and comorbidities, should be the driver for the clinical decisions in the older patients, beyond the chronological age [52] . A multicenter prospective study on the potential usefulness of the MPI in hospitalized older patients with COVID-19 is ongoing in the frame of the Special Interest Group on the Comprehensive Geriatric Assessment (SIG-on-CGA) of the European Geriatric Medicine Society (EuGMS) to clarify this issue [53] .

Ethical approval No ethical approval statement is required for this editorial article. 

in elderly undergoing transcatheter aortic valve implantation

Value of a comprehensive geriatric assessment for predicting one-year outcomes in patients undergoing transcatheter aortic valve implantation: results from the CGA-TAVI multicentre registry

Enteral tube feeding and mortality in hospitalized older patients: a multicenter longitudinal study

Effectiveness of multi-prognostic index in older patients with advanced malignancies treated with immunotherapy

Association between multidimensional prognostic index and hospitalization and mortality among older adults with chronic kidney disease on conservative or on replacement therapy

Multidimensional prognostic index (MPI) in elderly patients with acute myocardial infarction

Multidimensional prognostic index (MPI) score has the major impact on outcome prediction in elderly surgical patients with colorectal cancer: the FRAGIS study

Multidimensional prognostic index (MPI) predicts non-invasive ventilation failure in older adults with acute respiratory failure

Beyond age. Improvement of prognostication through physical and cognitive functioning for nursing home residents with COVID-19

The multidimensional prognostic index (MPI) for the prognostic stratification of hospitalized older patients with COVID-19: a prospective multicenter observational cohort study. Objectives, study design and expected outcomes